Cellbox Solutions GmbH Awarded €2.5 Million Grant Combined with an Equity Component of up to €10 Million Under the European Innovation Council’s Accelerator Program

– Cellbox Solutions selected by the EIC following the second 2023 EIC Accelerator cut-off

PRESS RELEASE. Cologne, Germany — July 05, 2023 – Cellbox Solutions GmbH, a leading provider of warm chain logistics solutions for the research, development and shipment of cell-based therapies and cellular diagnostics, today announced that the Company has been awarded an initial grant of €2.5 million combined with an additional equity funding of up to €10 million under the European Innovation Council (EIC) Accelerator program sponsored by the European Union.

Cellbox has established a significant global footprint in the life sciences R&D sector by enabling academic and industrial groups to transport difficult-to-freeze and non-freezable cell types such as organoids, tissue patches, cellular 3D prints and others. The initial grant will be used to further develop the Cellbox technology for the workflow of clinical trials and cell therapies for the cell and gene technology market. The equity component will be used to expand Cellbox´ logistics services and establish logistics hubs in Europe, the U.S., and APAC.
The two-year €2.5 million grant will be disbursed in August 2023 and will be complemented by the EIC Fund’s equity investment starting in early 2024.

“We are very proud that the EIC Accelerator jury has chosen to support Cellbox in the development and commercialization of its sophisticated warm chain logistics solutions in a fierce competition among numerous European start-up applicants,” said Kathrin Adlkofer, Prof. PhD, Founder of Cellbox Solutions GmbH. “Our goal is to bring our innovative and enabling live cell transport technology to key healthcare markets and ultimately to patients in Europe, the U.S. and Asia-Pacific.”

Cellbox Solutions´ technology is based on a unique portable live cell transport incubator combined with leading-edge live cell logistics solutions for healthcare companies.

###

About Cellbox Solutions GmbH
Founded in 2017, Cellbox Solutions GmbH focuses on innovative logistics solutions for the global healthcare industry, enabling transport logistics for difficult-to-freeze cells and clinical developers to deliver cell therapies to patients under the best physiological conditions. The Company´s portable CO2 incubator, Cellbox, provides a controlled and optimal environment for the transport of living cells and biological structures. Temperature and CO2 levels can be adjusted to ensure optimal incubation conditions.

For more information, please visit https://cellbox-solutions.com/

About the EIC and the EIC Accelerator Grant
The EIC was established by the European Commission as part of the EU´s Horizon Europe program. It provides funding to individual companies (mainly start-ups and SMEs) through both grants and investments. Investments currently take the form of direct equity or quasi-equity investments and are managed by the EIC Fund.

The EIC Accelerator offers start-ups and SMEs grants of up to €2.5 million ($2.5 million) combined with equity investments through the EIC Fund ranging from €500,000 to €15 million ($489,000 to $14.7 million) or more. In addition to financial support, all projects benefit from a range of business acceleration services that provide access to leading expertise, companies, investors and ecosystem players.

Contact Cellbox Solutions GmbH
Prof. Dr. Kathrin Adlkofer
COO and Founder
office@cellbox-solutions.com
+49 40 226 316 450

Media Inquiries
akampion
Dr. Ludger Wess / Ines-Regina Buth
Managing Partners
info@akampion.com
Tel. +49 40 88 16 59 64 /Tel. +49 30 23 63 27 68

 

 

 

Benzinga Logo
RESEARCH
Next-Level Trading Insights from our Team of Full-Time Trading Professionals
Summer Special for New Users!
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Posted In: NewsHealth CareFinancingPress Releases
Heart Surgeon Begs Americans: “Stop Doing This To Your Fruit”
The top 3 common foods that you would have never guessed were the cause of your fatigue.
Gundry MD
|
Sponsored
Plastic Surgeon Begs Women Over 40: “Stop Using Retinol Creams”
Beverly Hills MD
|
Sponsored
Tommy Chong: The Horrifying Truth About CBD
Tommy Chong’s CBD
|
Sponsored
Concerns Over A U.S. Default May Act As Another Major Catalyst For Gold
|
Sponsored
Here’s What A Walk-In Shower Should Cost
Dreamstyle Baths
|
Sponsored
Elon Musk Reiterates He’ll Eat McDonald’s Happy Meal On Live TV If Dogecoin Adoption By Golden Arches Becomes A Reality
Benzinga
10,643 ETH Worth $20M Was Just Burned
Benzinga
Exposed: Amazon Hates When Prime Members Do This, But They Can’t Stop You
Online Shopping Tools
|
Sponsored
This New Device Is Leaving Nеuropathy Experts Spееchless
Health Insight Journal
|
Sponsored
Heart Surgeon Begs Americans: “Stop Doing This To Your Avocados”
The top 3 common foods that you would have never guessed were the cause of your fatigue.
Gundry MD
|
Sponsored

Every Story That Matters Around The Web
Ozempic Patient Reveals Pains And Gains Of Using Popular Weight Loss Drug: ‘It Changed My Life’
McCarthy Faces Fresh Challenge Even Bigger Than Debt Ceiling: Preventing A Government Shutdown
Yuan Weakness Prompts Chinese Investors To Gravitate Towards Dollar Deposits, Hong Kong Insurance: Reuters
China In Default On Trillion-Dollar Debt To US Bondholders, Policy Expert Says ‘Failure To Act Needs To End Now’
Boomers Break The Mold, Choose Stock-Heavy Portfolios Over Bonds: WSJ
Saudi Arabia, Russia Deepen Oil Supply Cuts — Defying US Calls: Reuters
DON’T MISS YOUR FREE DAILY BRIEFING!
Email

Jobs For YouBY Amply

Relationship Banker – Spanish Required
Bank of America
Oakland Park

Search More Roles
News from Cision PR Newswire
DEX Crypto Trading Bots: How Carbon DeFi Changes The Game For Everyday Token Traders
by
James Wells, Benzinga Staff Writer
June 29, 2023 8:11 AM | 5 min read
Read in App
Advertiser Disclosure

Financial markets are becoming increasingly competitive, with the investment strategies of top-performing hedge funds dominated by automated or algorithmic trading – more than 50% of hedge funds employ bots to trade the majority of their capital. In the right hands, these trading bots can yield significant profits, passively generating income for investors. The cryptocurrency market, with its wild price swings, presents a lucrative opportunity to employ trading bots and capture major market moves. However, most trading bots operate on centralized exchanges, preventing traders from harnessing the core principles of crypto: decentralization and self-custody
READ MORE
Investor Anxiety Grows As VIX Index Records Dramatic Increase Amid Fed Rate Hike Concerns: Why Is Volatility Spiking Thursday?
by
Piero Cingari, Benzinga Staff Writer
July 6, 2023 12:31 PM | 3 min read
ZINGER KEY POINTS
Mounting concerns on upcoming Fed rate hikes spark stock market volatility, causing a sharp jump in the VIX index.
The VIX is on course to have its strongest session of 2023, topping the jump on March 8.

The CBOE Volatility (VIX) Index, commonly known as the “fear index,” surged over 20% on Thursday, reflecting the prevailing market volatility across major U.S. stock indices. With a daily change of 20%, the VIX is on track for its best session of 2023, topping the spike seen on March 8, when it soared 18.3% following the banking failures of Silicon Valley Bank and Signature Capital
READ MORE
Stocks Tumble, Yields Climb As Investors Fear Upcoming Rate Hikes Amid Booming Job Growth: What’s Driving Markets Thursday?
by
Shanthi Rexaline, Benzinga Editor
July 6, 2023 1:59 PM | 4 min read
ZINGER KEY POINTS
After stocks ran up to multimonth highs, they seem to have hit a rough patch as the Fed talks up the case for more rate hikes.
Traders will look ahead to each economic data point to gauge the economy’s strength, which in turn may have ramification for rates.

Thursday saw heightened risk aversion across markets, with all major U.S. indices losing ground and the VIX volatility Index rising by more than 17%, making it one of the most volatile days of the year so far. The release of a healthy ADP employment number raised investor expectations that the Federal Reserve may resume interest rate hikes and perhaps extend them beyond the summer. With 497,000 new jobs added in June, above May’s result of 267,000 and predictions of 228,000, concerns are growing that the Fed will become more hawkish
READ MORE
Timeplast Wants To Set A New Standard In Sustainable Plastics With Its Water-Soluble Plastic Substitute
by
Rachael Green, Benzinga Staff Writer
July 6, 2023 8:39 AM | 4 min read
Read in App
Advertiser Disclosure

Click here to invest in Timeplast and be a part of their growth journey making the world a greener place! Timeplast is a chemical technology startup that’s spent over a decade working on a water-soluble plastic substitute that eliminates many of the problems with both conventional plastics and current bioplastics without sacrificing the functionality and versatility of the material. The result is a material that behaves like conventional plastic but can be programmed to disappear at a predefined expiration date ranging from 60 seconds to 60 years of continuous contact with water
READ MORE
Meta’s Threads Crosses 10M Users Milestone In 7 Hours, Beats ChatGPT’s Record For Fastest To 1M Users
by
Rounak Jain, Benzinga Staff Writer
July 6, 2023 9:39 AM | 2 min read

Meta Platforms Inc.’s
META
-0.81%
+ Free Alerts
latest app Threads has now become the fastest app to cross the 1 million users mark, beating ChatGPT’s record. While ChatGPT took five days to cross 1 million users, Meta’s Threads reached the milestone in just one hour. There’s more – according to Mark Zuckerberg, Threads crossed 10 million users in seven hours. What Happened: Meta’s Threads app is off to a blistering start, becoming the fastest app to cross the 1 million users mark, reaching the milestone in one hour and beating ChatGPT’s record of five days
READ MORE
One For The Money: FTX, Not Taylor Swift, Called Off Potential Crypto Endorsement Deal, Says Report
by
Aaron Bry, Benzinga Editor
July 6, 2023 11:53 AM | 1 min read
ZINGER KEY POINTS
Contrary to prior reports, FTX was the one to back out of a potential endorsement deal with Taylor Swift.
Swift’s team was allegedly frustrated when FTX terminated the negotiations for a partnership.

Contrary to prior reports suggesting that pop superstar Taylor Swift turned down an endorsement opportunity with FTX, the world’s largest cryptocurrency exchange at the time, recent information from The New York Times paints a different picture. The new report alleges that it was FTX and its founder, Sam Bankman-Fried (SBF), who backed out of the agreement after months of negotiations, not Swift
READ MORE
Insider Buying: Hedge Fund Legend Makes A Series Of Stock Purchases In Premium Digital Smart Home Fitness Company Interactive Strength (NASDAQ: TRNR – “FORME”)
by
David Willey, Benzinga Staff Writer
July 5, 2023 7:46 AM | 2 min read
Read in App
Advertiser Disclosure
Notable hedge fund manager Bradley Wickens has made a series of insider purchases adding to his position of more than a 10% holder in premium digital smart home fitness company Interactive Strength Inc.
TRNR
-4.29%
+ Free Alerts
“FORME”))). FORME is a digital fitness platform that combines premium connected fitness hardware products with live virtual 1:1 personal training. The Company completed an IPO in May and aims to establish itself as a leader in the premium fitness training market by combining at-home convenience with cutting-edge personal training services through its award winning connected hardware products. Wickens, a UK-based hedge fund manager and founder of Broad Reach Investment Management, started with a 10% ownership stake in Interactive Strength. Wickens has made a series of share purchases since Interactive Strength’s initial public offering (IPO), and he increased his number of TRNR shares by over 120,000 during the month of May
READ MORE
Elon Musk Admits Getting Past FSD Predictions Wrong But Says Tesla Closer To It ‘Than We Have Ever Been’
by
Anan Ashraf, Benzinga Editor
July 6, 2023 5:42 AM | 2 min read

The 2023 World Artificial Intelligence Conference kickstarted in Shanghai on Thursday, with Tesla Inc
TSLA
-2.10%
+ Free Alerts
making its presence felt despite the absence of other U.S. AI players like Open AI. What Happened: Tesla CEO Elon Musk joined the opening ceremony via video and praised China’s potential in various sectors, including artificial intelligence. He expressed confidence in China’s strong AI capabilities
READ MORE
After Reels And Stories, Zuckerberg’s Imitation Game With Threads Turns Meta Analyst Even More Bullish: Here’s Why
by
Shanthi Rexaline, Benzinga Editor
July 6, 2023 4:45 AM | 1 min read

Meta Platforms, Inc.
META
-0.81%
+ Free Alerts
has finally launched its Twitter clone, Threads, to mixed reviews. However, this has not stopped an optimistic analyst from becoming even more bullish on the Mark Zuckerberg-led company’s stock. The Meta Analyst: KeyBanc Capital Markets analyst Justin Patterson, maintaining an Overweight rating, raised the price target from $280 to $335, suggesting a potential 14% upside from current levels
READ MORE
Lear Capital Gold IRA: What Is It And How To Invest?
by
Jad Malaeb, Benzinga Staff Writer
June 29, 2023 8:18 AM | 3 min read
Read in App
Advertiser Disclosure

Gold has emerged as one of the leading asset classes in 2023, rising 12% while standard market proxies fall behind. According to multiple analysts, it may be a while before the “gold rush” subsides. With political and economic instability brimming, many investors are eyeing gold as a means to protect their hard-earned cash and save for retirement. Investors can leverage gold to protect their cash through the purchase of gold-heavy stocks or exchange-traded funds (ETFs), but these options do not afford investors the luxury of physically owning gold. To do that, investors must sign up for a specific kind of financial account called an Individual Retirement Account (IRA), or purchase gold directly for home storage
READ MORE
Altria-Backed Cannabis Producer Cronos Group Considers Sale, Stock Waivers Amid Takeover Interest
by
Maureen Meehan, Benzinga Editor
July 6, 2023 3:54 PM | 2 min read
ZINGER KEY POINTS
The Cronos sale talks come at a time of uncertainty for the cannabis industry.
Prior to Thursday’s speculation, Cronos shares had lost a quarter of their value year-to-date.

Cronos Group Inc
CRON
-4.08%
+ Free Alerts
is exploring options that could include a potential sale after attracting acquisition interest, Reuters reported Thursday, citing people familiar with the matter. The Canadian cannabis producer backed by cigarette maker Altria Group Inc.
MO
+0.24%
+ Free Alerts
, which has a market value of CA$972 million ($727.54 million), is purportedly working with a financial adviser to handle expressions of interest in a deal from other companies, including Curaleaf Holdings Inc
CURLF
, the report said
READ MORE
Uh Oh, Musk: Survey Finds Twitter Changes Will Force Users To Zuckerberg’s Alternative, Threads
by
Aj Fabino, Benzinga Staff Writer

July 6, 2023 2:05 PM | 3 min read
ZINGER KEY POINTS
Meta’s Threads sees record sign-ups amid Twitter’s looming TweetDeck paywall.
Benzinga survey suggests Twitter’s TweetDeck change will push users to Meta’s free alternative.

A survey conducted by Benzinga this week suggests that changes to Elon Musk’s Twitter could drive users towards Mark Zuckerberg’s new social media platform, Threads. What Happened: Launched by Instagram on Wednesday, Threads is an app that closely resembles Twitter’s feed of real-time, text-based conversations. Users can post text messages limited to 500 characters, and the app also supports photos and videos
READ MORE
H.C. Wainwright Reiterates Buy Rating For Agile Therapeutics (NASDAQ: AGRX), Citing Growing Demand For Twirla, A Weekly Low Dose Birth Control Patch
by
Rachael Green, Benzinga Staff Writer
June 29, 2023 8:48 AM | 3 min read
Read in App
Advertiser Disclosure

H.C. Wainwright & Co, reiterated its buy rating on Agile Therapeutics, Inc.
AGRX
-7.23%
+ Free Alerts
this month, setting a price target of $12 per share. The $12 price target is based on the 1:50 reverse split and the $7.5 million raised in Agile’s public offering in May. Despite challenges faced by the women’s healthcare company, its patented weekly birth control patch has seen a steady increase in demand, and the company is leveraging key partnerships to expand adoption even further. The Affordable Care Act of 2010 guarantees contraceptive coverage at no extra cost for patients in all states. That includes coverage for a broad range of birth control methods including pills, rings, implants, emergency contraception, and, crucially, any new contraceptives approved by the FDA
READ MORE
June Jobs Report Preview: Strong Employment Momentum Hints At Upside Surprise In Nonfarm Payrolls Data
by
Piero Cingari, Benzinga Staff Writer
July 6, 2023 3:35 PM | 3 min read
ZINGER KEY POINTS
Economists’ consensus forecasts NFPs to drop from 339,000 to 225,000 in June, but an impressive ADP growth may change the picture.
To fall short of estimates, June NFPs would have to be at least 273,000 lower than the most recent ADP data.

With Friday on the horizon, investors are eagerly anticipating the Bureau of Labor Statistics’ job market report for June. This report will reveal crucial data points, including the non-farm payrolls (NFPs), hourly wage growth, and the unemployment rate, providing a key snapshot of the country’s labor market condition. The data will also provide valuable insights, potentially shaping market sentiment and influencing the Federal Reserve’s upcoming decisions on interest rates
READ MORE
Trump’s Legal Woes Have A Silver Lining? 2024 Campaign Funding Reportedly Doubles To $35M After Mar-A-Lago Indictment
by
Shanthi Rexaline, Benzinga Editor
July 6, 2023 6:00 AM | 1 min read

Former President Donald Trump is knee-deep in legal troubles but that has not impacted the copious amount of funds flowing into his 2024 campaign coffer. What Happened: Trump’s fund-raising committee collected $35 million in the second quarter, according to a campaign official, Politico reported. This compares to the $18.8 million raised in the first quarter, it added
READ MORE
View More Top Stories
Popular Channels
PreMarket Prep
Press Releases
Analyst Ratings
News
Options
ETFs
Tools & Features
Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst
Partners & Contributors
Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO
About Benzinga
About Us
Careers
In The News
Events
Contact Us
Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap
© 2023 Benzinga | All Rights Reserved